GENERIC - The Salt Lake Tribune http://www.sltrib.com/feeds/topics/GENERIC News from The Salt Lake Tribune en-us webmaster@sltrib.com (Webmaster) Kids’ hospitalizations linked to anti-addiction drug http://www.sltrib.com/sltrib/world/58413957-68/drug-tablets-buprenorphine-available.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58413957-68/drug-tablets-buprenorphine-available.html.csp">Kids’ hospitalizations linked to anti-addiction drug</a></h4> <span class="author vcard"><span class="fn">By LINDSEY TANNER</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-09-14T20:15:01.912-06:00">Updated Sep 14, 2014 08:15PM MDT</span></h5> <div class ="entry-content">Chicago • An anti-addiction drug used to fight the nation’s heroin and painkiller abuse epidemics poses a threat to young children who accidentally swallow relatives’ prescriptions, a federal study says. Some children have died. The study found that the drug, buprenorphine, was the adult prescription medication most commonly implicated in emergency hospitalizations of children aged 6 and younger. For every 100,000 patients prescribed buprenorphine, 200 young children were hospitalized for takin...</div> <h5><a rel="item-license" href="#license-584139572014-09-14T20:15:01.912-06:00" id="#license-2014-09-14T20:15:01.912-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58413957@www.sltrib.com Sun, 14 Sep 2014 20:15:01 MDT FTC sues AbbVie, Teva over generic AndroGel http://www.sltrib.com/sltrib/money/58390459-79/abbvie-teva-generic-androgel.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58390459-79/abbvie-teva-generic-androgel.html.csp">FTC sues AbbVie, Teva over generic AndroGel</a></h4> <span class="author source-org vcard"><span class="org fn">The Associated Press</span></span> <h5><span class="updated" title="2014-09-08T17:30:01.736-06:00">Updated Sep 8, 2014 05:30PM MDT</span></h5> <div class ="entry-content">New York • The Federal Trade Commission is suing drugmakers AbbVie and Teva, saying they conspired to temporarily keep generic versions of AbbVie’s low-testosterone drug AndroGel off the market. The FTC says AbbVie Inc. and its partner and Besins Healthcare filed baseless patent infringement lawsuits against Teva Pharmaceutical Industries Ltd. and Perrigo Co. to delay the approval and sale of less-expensive generic versions of the drug. AbbVie then struck a deal with Teva that will allow Teva to...</div> <h5><a rel="item-license" href="#license-583904592014-09-08T17:30:01.736-06:00" id="#license-2014-09-08T17:30:01.736-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58390459@www.sltrib.com Mon, 08 Sep 2014 17:30:01 MDT